Clinical trial

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections…

NCT00361517 · Singapore General Hospital, Other · Completed

Key facts

NCT number NCT00361517
Title To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early
Official title Using Serum Galactomannan Levels in a Prospective, Randomised, Non-blinded Trial to Guide Early Anti-fungal Therapy in Haematology Patients at Risk of Invasive Aspergillosis.
Lead sponsor Singapore General Hospital, Other
Collaborators National University Hospital, Singapore
Status Completed
Phase Phase 3
Study type Interventional
Conditions Aspergillosis
Intervention type Behavioral, Drug, Other
Interventions Galactomannan antigen monitoring, Aspergillus PCR, blood draws, blood draws for GM monitoring, Amphotericin-B deoxycholate, blood test, Blood test
Enrollment 47
Start date Jun 1, 2006
Primary completion Oct 30, 2007
Completion Jun 30, 2009
First posted Aug 8, 2006
Last update posted Sep 26, 2018
Countries Singapore

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies